A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

Nature Medicine

Volumn 4, Issue 4, 1998, Pages 452-455

  Crook, Richard ^a   Verkkoniemi, Auli ^b   Perez Tur, Jordi ^a   Mehta, Nitin ^a   Baker, Matt ^a   Houlden, Henry ^a   Farrer, Matt ^a   Hutton, Mike ^a   Lincoln, Sarah ^a   Hardy, John ^a   Gwinn, Katrina ^c   Somer, Mirja ^d   Paetau, Anders ^b   Kalimo, Hannu ^e,f   Ylikoski, Raija ^b   Pöyhönen, Minna ^g   Kucera, Steve ^h   Haltia, Matti ^b  

^a MAYO CLINIC   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c MAYO CLINIC   (United States)

^d Vaestoliitto   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF TAMPA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DEMENTIA; EXON; FEMALE; FINLAND; GENE DELETION; HUMAN; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SENILE PLAQUE; SPASTIC PARESIS; VASCULAR AMYLOIDOSIS;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; EXONS; FEMALE; FINLAND; HUMANS; INTRONS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PEDIGREE; POLYMERASE CHAIN REACTION; PRESENILIN-1; RNA, MESSENGER; SENILE PLAQUES; SEQUENCE DELETION; SPASTIC PARAPLEGIA, HEREDITARY; VARIATION (GENETICS);

GOSSYPIUM HIRSUTUM;

EID: 0031949628     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0498-452     Document Type: Article

References (24)

1. Goate, A.M. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991)
2. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1995).
3. Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977 (1995).
4. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci: 20, 154-159 (1997).
5. Hutton, M. & Hardy, J. The presenilins and Alzheimer's disease. Human Mol. Genet. 6, 1639-1646 (1997).
6. Perez-Tur, J. et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin 1 gene. Neuroreport 7, 204-207 (1995).
7. Kwok, J.B.J. et al. Two novel (M233T and R278T) presenilin 1 mutations in early onset Alzheimer's disease and preliminary evidence for association of presenilin 1 mutations with a novel phenotype. Neuroreport 8, 1537-1542 (1997).
8. Sato, S. et al. Splicing mutation of presenilin 1 gene for early onset, familial Alzheimer's desease. Human Mutation (in the press).
9. Mehta, N.M. et al. Increased Aβ42(43) from cell lines expressing presenilin 1 mutations. Annals Neurol. (in the press).
10. Hutton, M. et al. Complete analysis of the presenilin 1 gene in families with early onset Alzheimer's disease. Neuroreport 7, 801-805 (1996).
11. Ploughman, L.M. & Boehnke, M. Estimating the power of a proposed linkage study for a complex genetic trait. Am. J. Hum. Genet. 44, 543-551 (1989).
12. Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (1996).
13. Levitan, D. et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 93, 14940-14944 (1996).
14. Baumeister, R. et al. Proteolytic cleavage of the Alzheimer's disease associated presenilin 1 is not required for its function in Caenorhabditis elegans notch signaling. Genes Func. 1, 149-159. (1997).
15. Clarke, R.F. et al. The structure of the presenilin-1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet. 11, 219-222 (1995).
16. Haltia, M. et al. Chromosome 14 encoded Alzheimer's disease: genetic and clinico-pathological description. Ann. Neurol. 36, 362-367 (1994).
17. Lowe, J., Lennox, G. & Leigh P.N. Disorders of movement and system degenerations. In Graham D.I., Lantos P.L. (Eds.): Greenfield's Neuropathology, sixth edition. Arnold, London 1997, pp. 281-366
18. Mullan, M. et al. Clinical features of early onset, familial Alzheimer's disease linked to chromosome 14. Neuropsychiatric Genet. 60, 44-52 (1995).
19. Ishii, K. et al. Increased Aβ42(43)-plaque deposition in early onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in ths PS-1 gene. Neurosci. Letts. 228, 17-20 (1997).
20. Dickson D.W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56, 321-329 (1997).
21. Schmidt, M.L., Lee, V.M.-Y., Forman, M., Chiu, T.-S. & Trojanowski, J.Q. Monoclonal antibodies to a 100-kd protein reveal abundant Aβ-negative plaques throughout gray matter of Alzheimer's disease brains. Am. J. Pathol. 151, 69-80 (1997).
22. Probst, A., Langui, D. & Ulrich, J. Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1, 229-239 (1991).
23. Mann, D.M.A. et al. Amyloid-(protein (Aβ) deposition in chromosome 14 linked Alzheimer's disease: predominance of Aβ42(43). Ann. Neurol. 40, 149-156 (1996).
24. Castano, E.M. et al. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein. Biochem. Biophys. Res. Comm. 141, 782-789 (1986).